1. A Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy. (2021) Authors: Baik, Christina; Lee, Sylvia; Cook, Kitty; Wallace, Sarah; Wood, Rebecca; Santana-Davila, Rafael; Chow, Laura; Rodriguez, Cristina; Eaton, Keith D.; Martins, Renato Journal: Cancer treatment and research communications Issue: Number 28(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients. Issue 2 (1st August 2015) Authors: Fang, Min; Becker, Pamela S.; Linenberger, Michael; Eaton, Keith D.; Appelbaum, Frederick R.; Dreyer, ZoAnn; Airewele, Gladstone; Redell, Michele; Lopez-Terrada, Dolores; Patel, Ankita; Rabin, Karen R.; Lu, Xinyan Journal: American journal of clinical pathology Issue: Volume 144:Issue 2(2015) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An open-label, phase II study of the polo-like kinase-1 (Plk-1) inhibitor, BI 2536, in patients with relapsed small cell lung cancer (SCLC). (February 2017) Authors: Awad, Mark M.; Chu, Quincy S-C; Gandhi, Leena; Stephenson, Joe J.; Govindan, Ramaswamy; Bradford, Daniel S.; Bonomi, Philip D.; Ellison, David M.; Eaton, Keith D.; Fritsch, Holger; Munzert, Gerd; Johnson, Bruce E.; Socinski, Mark A. Journal: Lung cancer Issue: Volume 104(2017) Page Start: 126 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non–Small-Cell Lung Cancer. Issue 8 (August 2021) Authors: Merkhofer, Cristina; Chennupati, Shasank; Sun, Qin; Eaton, Keith D.; Martins, Renato G.; Ramsey, Scott D.; Goulart, Bernardo H. L. Journal: JCO oncology practice Issue: Volume 17:Issue 8(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of Diagnostic Delays on Lung Cancer Survival Outcomes: A Population Study of the US SEER-Medicare Database. Issue 6 (4th June 2022) Authors: Romine, Perrin E.; Sun, Qin; Fedorenko, Catherine; Li, Li; Tang, Mariel; Eaton, Keith D.; Goulart, Bernardo H.L.; Martins, Renato G. Journal: JCO oncology practice Issue: Volume 18:Issue 6(2022) Page Start: e877 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Meaningful measures for advanced cancer: Building a measure set to promote goal-concordant care. Issue 28 (1st October 2022) Authors: McNiff Landrum, Kristen K.; Ross, Tom; Andiel, Corinna; Eaton, Keith D.; Edge, Stephen B.; George, Marina C.; Lakin, Joshua; Morse, Denise; Papio, Joseph; Plank, Wendy; Thacker, Lauren; Thompson, Emily; Zachariah, Finly; Kolosky, Jack Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients. (29th March 2022) Authors: Chalker, Cameron; Voutsinas, Jenna M.; Wu, Qian Vicky; Santana‐Davila, Rafael; Hwang, Victoria; Baik, Christina S.; Lee, Sylvia; Barber, Brittany; Futran, Neal D.; Houlton, Jeffrey J.; Laramore, George E.; Liao, Jay Justin; Parvathaneni, Upendra; Martins, Renato G.; Eaton, Keith D.; Rodriguez, Cr... Journal: Cancer medicine Issue: Volume 11:Number 22(2022) Page Start: 4104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies. Issue 3 (28th December 2017) Authors: Rodriguez, Cristina P.; Martins, Renato G.; Baik, Christina; Chow, Laura Q.; Santana‐Davila, Rafael; Goulart, Bernardo H.; Lee, Sylvia; Eaton, Keith D. Journal: Head & neck Issue: Volume 40:Issue 3(2018) Page Start: 584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Predictors of outcome with cetuximab and paclitaxel for head and neck squamous cell carcinoma. (1st December 2016) Authors: Pellini Ferreira, Bruna; Redman, Mary; Baker, Kelsey K.; Martins, Renato; Eaton, Keith D.; Chow, Laura Quan Man; Baik, Christina S.; Goulart, Bernardo; Lee, Sylvia Mina; Santana‐Davila, Rafael; Rodriguez, Cristina P. Journal: Laryngoscope Issue: Volume 127:Number 7(2017) Page Start: 1583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Socioeconomic factors and outcomes among patients with recurrent/metastatic head and neck cancer receiving immunotherapy. Issue 28 (1st October 2022) Authors: Uy, Natalie F.; Ng, Kevin; Voutsinas, Jenna M.; Wu, Vicky; Merkhofer, Cristina Maria; Tseng, Diane; Giustini, Nicholas Peter; Lee, Sylvia; Baik, Christina S; Santana-Davila, Rafael; Eaton, Keith D.; Rodriguez, Cristina P. Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗